Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125534431 | 12553443 | 1 | I | 20160605 | 20160630 | 20160713 | 20160713 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-054944 | BRISTOL MYERS SQUIBB | 82.80 | YR | F | Y | 0.00000 | 20160713 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125534431 | 12553443 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 1.5 MG, QD | Y | 9218 | 1.5 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125534431 | 12553443 | 1 | Pulmonary embolism |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125534431 | 12553443 | HO |
125534431 | 12553443 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125534431 | 12553443 | Fall | |
125534431 | 12553443 | Haemorrhage intracranial | |
125534431 | 12553443 | Head injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125534431 | 12553443 | 1 | 201602 | 20160605 | 0 |